SeqOnce develops assays and reagents for molecular biology research, including next-generation sequencing (NGS) products and qPCR assays for pathogen detection. Their solutions enhance the speed and accuracy of diagnostics, supporting conservation efforts for threatened and endangered species.
Funding
Funding not disclosed
Founders
Product
Problem
Molecular biology researchers and diagnostic labs require rapid, accurate, and cost-effective tools for pathogen detection and genetic analysis. Traditional methods can be time-consuming, expensive, and may not be compatible with various open-source instruments.
Solution
SeqOnce Biosciences develops and manufactures a suite of qPCR assays, NGS library preparation kits, and amplification master mixes designed to accelerate molecular biology workflows. Their products focus on speed, ease of use, and compatibility with open-source platforms, enabling researchers to quickly generate informative data. SeqOnce's assays target a range of applications, including pathogen detection, microbiome analysis, and antibiotic resistance screening. By offering rapid customer support and technical assistance, SeqOnce aims to streamline the research process and empower scientists to focus on discovery.
Target Audience
SeqOnce's primary customers include molecular biology researchers, diagnostic laboratories, and conservation organizations involved in pathogen surveillance, microbiome research, and species conservation efforts.
Features
- AmphiSense qPCR panels for rapid detection of respiratory pathogens
- Amur qPCR panels for sexually transmitted infections and vaginal/urinary microbiota analysis
- Glyphis qPCR panel for wound microbiota analysis and antibiotic resistance genes
- RhinoSeq DNA Library Prep kit for next-generation sequencing
- SeqOnce Amplification Master Mixes for robust and efficient PCR
- Assays and reagents validated for use on open-source qPCR instruments
- Field Application Specialists provide technical support for protocol development and troubleshooting